TP53 mutations in favorable-risk Wnt/Wingless-subtype medulloblastomas

J Clin Oncol. 2011 Apr 20;29(12):e344-6; author reply e347-8. doi: 10.1200/JCO.2010.33.8590. Epub 2011 Feb 28.
No abstract available

Publication types

  • Comment
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cerebellar Neoplasms / genetics*
  • Cerebellar Neoplasms / mortality
  • Cerebellar Neoplasms / pathology
  • Cerebellar Neoplasms / therapy
  • Genetic Predisposition to Disease
  • Humans
  • Medulloblastoma / genetics*
  • Medulloblastoma / mortality
  • Medulloblastoma / pathology
  • Medulloblastoma / therapy
  • Mutation*
  • Phenotype
  • Prognosis
  • Risk Assessment
  • Risk Factors
  • Tumor Suppressor Protein p53 / genetics*
  • Wnt Proteins / genetics*

Substances

  • TP53 protein, human
  • Tumor Suppressor Protein p53
  • Wnt Proteins